HRP20030381B1 - 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A - Google Patents

3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A

Info

Publication number
HRP20030381B1
HRP20030381B1 HR20030381A HRP20030381A HRP20030381B1 HR P20030381 B1 HRP20030381 B1 HR P20030381B1 HR 20030381 A HR20030381 A HR 20030381A HR P20030381 A HRP20030381 A HR P20030381A HR P20030381 B1 HRP20030381 B1 HR P20030381B1
Authority
HR
Croatia
Prior art keywords
meaning
individual
group
hydrogen
aza
Prior art date
Application number
HR20030381A
Other languages
English (en)
Croatian (hr)
Inventor
Maru�i�-I�tuk Zorica
Kujund�i� Nedjeljko
Mutak Stjepan
Original Assignee
GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. filed Critical GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.
Priority to HR20030381A priority Critical patent/HRP20030381B1/xx
Priority to PT04732143T priority patent/PT1631575E/pt
Priority to EP04732143A priority patent/EP1631575B1/en
Priority to JP2006530610A priority patent/JP2007501268A/ja
Priority to PCT/HR2004/000014 priority patent/WO2004101591A1/en
Priority to DE602004003054T priority patent/DE602004003054T2/de
Priority to PL04732143T priority patent/PL1631575T3/pl
Priority to DK04732143T priority patent/DK1631575T3/da
Priority to US10/557,025 priority patent/US20070066544A1/en
Priority to ES04732143T priority patent/ES2274453T3/es
Priority to CA002525143A priority patent/CA2525143A1/en
Priority to AT04732143T priority patent/ATE344270T1/de
Priority to YUP-2005/0837A priority patent/RS20050837A/sr
Priority to CNB2004800130438A priority patent/CN100345860C/zh
Priority to SI200430155T priority patent/SI1631575T1/sl
Priority to CL200401026A priority patent/CL2004001026A1/es
Priority to ARP040101631A priority patent/AR044320A1/es
Publication of HRP20030381A2 publication Critical patent/HRP20030381A2/hr
Priority to IS8109A priority patent/IS8109A/is
Priority to HK06112660A priority patent/HK1092156A1/xx
Priority to CY20071100033T priority patent/CY1107321T1/el
Publication of HRP20030381B1 publication Critical patent/HRP20030381B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
HR20030381A 2003-05-14 2003-05-14 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A HRP20030381B1 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
HR20030381A HRP20030381B1 (en) 2003-05-14 2003-05-14 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
ES04732143T ES2274453T3 (es) 2003-05-14 2004-05-11 Nuevos derivados 3-decladinosil 9a-n-carbamoilicos y 9a-n-tiocarbamoilicos de 9-desoxo-9-dihidro-9a-aza-9a-homoeritromicina a.
YUP-2005/0837A RS20050837A (en) 2003-05-14 2004-05-11 NEW 3-DECLADINOSYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A- HOMOERYTHROMYCIN A NEW 3- DECLADINOSYL 9A-N-CARBAMOYL AND -A- N-THIOCARBAMOYL DERIVATIVES OF 9- DEOX-9-DIHYDRO-9A-AZA-9A- HOMOERYTHROMYCIN A
JP2006530610A JP2007501268A (ja) 2003-05-14 2004-05-11 新規な9−デオキソ−9−ジヒドロ−9a−アザ−9a−ホモエリスロマイシンAの3−デクラジノシル9a−N−カルバモイル及び9a−N−チオカルバモイル誘導体
PCT/HR2004/000014 WO2004101591A1 (en) 2003-05-14 2004-05-11 NEW 3-DECLADINOSYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A-HOMOERYTHROMYCIN A
DE602004003054T DE602004003054T2 (de) 2003-05-14 2004-05-11 Neue 3-decladinosyl-9a-n-carbamoyl- und 9a-n-thiocarbamoylderivate von 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a
PL04732143T PL1631575T3 (pl) 2003-05-14 2004-05-11 Nowe 3-dekladinozylo-9a-N-karbamoilowe i 9a-N-tiokarbamoilowe pochodne 9-deokso-9-dihydro-9a-aza-9a homoerytromycyny A
DK04732143T DK1631575T3 (da) 2003-05-14 2004-05-11 Nye 3-decladinosyl-9a-N-carbamoyl- og 9a-N-thiocarbamoylderivater af 9-deox-9-dihydro-9a-AZA-9A-homoerythromycin A
US10/557,025 US20070066544A1 (en) 2003-05-14 2004-05-11 3-Decladinosyl 9a-n-carbamoyl and 9a-n-thiocarbamoyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a
PT04732143T PT1631575E (pt) 2003-05-14 2004-05-11 NOVOS DERIVADOS 3- DECLADINOSIL 9ª-N-CARBAMOIL E 9ª-N- TIOCARBAMOIL DE 9-DESOXI-9-DI-HIDRO-9ª-AZA-9ª-HOMOERITROMICINA
CA002525143A CA2525143A1 (en) 2003-05-14 2004-05-11 New 3-decladinosyl 9a-n-carbamoyl and 9a-n-thiocarbamoyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a
AT04732143T ATE344270T1 (de) 2003-05-14 2004-05-11 Neue 3-decladinosyl-9a-n-carbamoyl- und 9a-n- thiocarbamoylderivate von 9-deoxo-9-dihydro-9a- aza-9a-homoerythromycin a
EP04732143A EP1631575B1 (en) 2003-05-14 2004-05-11 NEW 3-DECLADINOSYL 9a-N -CARBAMOYL AND 9a-N -THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A-HOMOERYTHROMYCIN A
CNB2004800130438A CN100345860C (zh) 2003-05-14 2004-05-11 新的9-脱氧-9-二氢-9A-氮杂-9A-高红霉素A的3-去红霉糖基9a-N-氨基甲酰基和9a-N-硫代氨基甲酰基衍生物
SI200430155T SI1631575T1 (sl) 2003-05-14 2004-05-11 NOVI 3-DEKLADINOZIL 9a-N-KARBAMOILNI IN 9a-N-TIOKARBAMOILNI DERIVATI 9-DEOKS-9-DIHIDRO-9a-AZA-9a-HOMOERITROMICINA A
CL200401026A CL2004001026A1 (es) 2003-05-14 2004-05-13 COMPUESTOS DERIVADOS DE 3-DECLADINOSILO DE 9a-N-CARBAMOIL Y 9a-N-TIOCARBAMOIL-9-DEOXO-9-DIHIDRO-9a-AZA-9a-HOMOERITROMICINA A; Y PROCEDIMIENTO DE PREPARACION, UTILES COMO AGENTES ANTIBACTERIANOS.
ARP040101631A AR044320A1 (es) 2003-05-14 2004-05-14 Derivados 3-decladinosilo de la clase de 9a - n-carbamoil - y 9a-ntiocarbamoil- 9 dihidro-9a aza- 9a - homoeritromicina a
IS8109A IS8109A (is) 2003-05-14 2005-10-31 Nýjar 3-dekladínósýl 9a-N-karbamóýl og 9a-N-þíókarbamóýl afleiður af 9-deoxó-9-díhýdró-9a-asa-9a-hómóerýþrómýsíni A
HK06112660A HK1092156A1 (en) 2003-05-14 2006-11-17 New 3-decladinosyl 9A-N-carbamoyl and 9A-N-thiocarbamoyl derivatives of 9-deox-9-di-hydro-9A-aza-9A homoerythromycin a
CY20071100033T CY1107321T1 (el) 2003-05-14 2007-01-10 Νεα 3-δεκλαδινοσυλ-9α-ν-καρβaμοϋλικα και 9α-ν-θειοκαρβαμοϋλικα παραγωγα της 9-δεσοξο-9-διυδρο-9α-αζα-9α-ομοepυθρομυκινης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR20030381A HRP20030381B1 (en) 2003-05-14 2003-05-14 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A

Publications (2)

Publication Number Publication Date
HRP20030381A2 HRP20030381A2 (en) 2005-02-28
HRP20030381B1 true HRP20030381B1 (en) 2007-05-31

Family

ID=33446264

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030381A HRP20030381B1 (en) 2003-05-14 2003-05-14 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A

Country Status (20)

Country Link
US (1) US20070066544A1 (is)
EP (1) EP1631575B1 (is)
JP (1) JP2007501268A (is)
CN (1) CN100345860C (is)
AR (1) AR044320A1 (is)
AT (1) ATE344270T1 (is)
CA (1) CA2525143A1 (is)
CL (1) CL2004001026A1 (is)
CY (1) CY1107321T1 (is)
DE (1) DE602004003054T2 (is)
DK (1) DK1631575T3 (is)
ES (1) ES2274453T3 (is)
HK (1) HK1092156A1 (is)
HR (1) HRP20030381B1 (is)
IS (1) IS8109A (is)
PL (1) PL1631575T3 (is)
PT (1) PT1631575E (is)
RS (1) RS20050837A (is)
SI (1) SI1631575T1 (is)
WO (1) WO2004101591A1 (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080200403A1 (en) * 2005-01-14 2008-08-21 Glaxosmithkline 9A-Carbamoyl and Thiocarbamoyl Azalides with Anti-Inflammatory Activity
ATE429921T1 (de) * 2005-01-14 2009-05-15 Glaxosmithkline Zagreb 9a-carbamoyl- und thiocarbamoylazalide mit antimalariawirkung
EP2988597B1 (en) 2013-04-04 2022-06-08 President and Fellows of Harvard College Macrolides and methods of their preparation and use
CN104119413B (zh) * 2014-07-29 2016-08-24 华中农业大学 一种土拉霉素残留标示物的合成方法
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
CN113573779A (zh) * 2018-11-19 2021-10-29 齐卡尼治疗股份有限公司 C10-亚烷基取代的13元大环内酯及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
HRP990130B1 (en) * 1999-05-03 2004-06-30 Pliva D D HALOGEN DERIVATIVES 9a-N-(N'-ARYLCARBAMOYL)- AND 9a-N-(N'-ARYLTHIOCARBAMOYL)-9-DEOXO-9a-AZA-9a OF HOMOERYTHROMYCIN A
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
HRP20010146B1 (en) * 2001-02-28 2005-10-31 Pliva D.D. 9a-N-(N'-(PHENYLSULFONYL)CARBAMOYL) DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMYCIN A AND OF 5-O-DESOSAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHRONOLIDE A
US6933283B2 (en) * 2002-04-25 2005-08-23 Abbott Laboratories 11-deoxy azalide antibacterials

Also Published As

Publication number Publication date
EP1631575A1 (en) 2006-03-08
DK1631575T3 (da) 2007-02-26
DE602004003054T2 (de) 2007-06-06
ATE344270T1 (de) 2006-11-15
HRP20030381A2 (en) 2005-02-28
WO2004101591A1 (en) 2004-11-25
ES2274453T3 (es) 2007-05-16
IS8109A (is) 2005-10-31
HK1092156A1 (en) 2007-02-02
CY1107321T1 (el) 2012-11-21
CN1788013A (zh) 2006-06-14
SI1631575T1 (sl) 2007-04-30
PT1631575E (pt) 2007-01-31
CA2525143A1 (en) 2004-11-25
PL1631575T3 (pl) 2007-03-30
JP2007501268A (ja) 2007-01-25
US20070066544A1 (en) 2007-03-22
DE602004003054D1 (de) 2006-12-14
AR044320A1 (es) 2005-09-07
CN100345860C (zh) 2007-10-31
EP1631575B1 (en) 2006-11-02
CL2004001026A1 (es) 2005-04-22
RS20050837A (en) 2007-12-31

Similar Documents

Publication Publication Date Title
RS50519B (sr) Supstituisani derivati 8'-piri(mi)dinil-dihidrospiro- /cikloalkilamin/-pirimido/1,2-a/pirimidin-6-ona
RS51136B (sr) Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba
RS51943B (en) PIPERIDINSKI GPCR AGONIST
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
TW200606137A (en) Urea derivatives
HRP20050895B1 (hr) Ftalazinon derivati
HRP20070529T3 (en) Imidazole derivatives as glutmate receptor antagonists
CO4970780A1 (es) Nuevos compuestos heterociclicos de piridazina
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
RS51937B (sr) Derivati heterociklokarboksamida
ME01421B (me) 5-supstituisani derivati kinazolinona kao protivtumorska sredstva
BR0213140A (pt) Fungicidas de pirazol-pirimidina
ATE338754T1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
HRP20050390A2 (en) Substituted benzoxazinones and uses thereof
CY1106398T1 (el) 6,7-διυδρο-5η-πυραζολο[1,2-α]πυραζολ-1-ονες οι οποιες ελεγχουν φλεγμονωδεις κυτοκινες
MEP7808A (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
RS52562B (en) (3-ARIL-PIPERAZINE-1-IL) DERIVATI 6,7-DIALCOKSIQUINZOLINE, 6,7-DIALCOKSIFTALAZINE I
RS51193B (sr) Hidantoinski derivati korisni kao inhibitori metaloproteinaza
HRP20030381B1 (en) 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
MY140325A (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
RS52495B (en) SULPHONYL-HINOLINE DERIVATIVES
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
RS50905B (sr) Derivati benzopirana supstituisani sa sekundarnim aminima uključujući tetrazol, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
CO5080758A1 (es) DERIVADOS DE 3-(2-oxo-[1,3´]BIPIRROLODINIL-3-ILIDENMETIL
RS50791B (sr) Farmaceutske kombinacije zasnovane na derivatima piridoindolona

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O.,

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080421

Year of fee payment: 6

PBON Lapse due to non-payment of renewal fee

Effective date: 20090515